|
Volumn 109, Issue 5675, 1999, Pages 26-27
|
Health economics. Perfect combination.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ARTICLE;
COST BENEFIT ANALYSIS;
DRUG COMBINATION;
DRUG COST;
ECONOMICS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFORMATION PROCESSING;
NATIONAL HEALTH SERVICE;
PUBLICATION;
UNITED KINGDOM;
ANTI-HIV AGENTS;
COST-BENEFIT ANALYSIS;
DATA COLLECTION;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
FORMULARIES;
GREAT BRITAIN;
HIV INFECTIONS;
HUMANS;
STATE MEDICINE;
|
EID: 0033533626
PISSN: 09522271
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|